The fallout from the Dengvaxia scandal reached new heights on Friday as the Philippine Department of Justice found “probable cause” to indict Sanofi (SNY), a half-dozen of its employees, and several current and former Philippines health officials over a series of deaths related to the dengue virus vaccine.

The authorities alleged that charges should be brought for “reckless imprudence resulting (in) homicide” in connection with “irregularities” and lapses in purchasing and approving the use of the Sanofi vaccine, as well as rolling out an immunization program. The company was cited for failing to actively monitor patients and failing to provide assistance after serious adverse events were reported.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • It seems each of the 20 faces up to 60 years (6 x 10 counts), but given Mr Duarte’s alleged propensity for extra-legal executions, perhaps this counts as a measured legal response? Just a thought ….

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy